PUT - SPRINTER OPEN END - STRYKER CORP. Share Price

Certificat

DE000VM55EA2

Delayed Deutsche Boerse AG 09:36:44 02/07/2024 BST
6.06 EUR +0.66% Intraday chart for PUT - SPRINTER OPEN END - STRYKER CORP.
Current month+7.12%
1 month+6.36%
Date Price Change
02/07/24 6.06 +0.66%
01/07/24 6.02 +7.12%
28/06/24 5.62 -1.92%
27/06/24 5.73 +0.88%
26/06/24 5.68 -4.38%

Delayed Quote Deutsche Boerse AG

Last update July 02, 2024 at 09:36 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55EA
ISINDE000VM55EA2
Date issued 29/11/2023
Strike 399.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 10.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.38
Lowest since issue 3.66
Spread 0.19
Spread %3.07%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
336.5 USD
Average target price
372.9 USD
Spread / Average Target
+10.83%
Consensus